A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus
Clinical trial NCT05155345 · COMPLETED
Trial details
- NCT number
- NCT05155345
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2024-12-17
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.